• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
β-cell self-destruction and extremely complicated and still unknown etiopathogenesis of type 1 diabetes.β 细胞的自身破坏和 1 型糖尿病极其复杂且仍未知的病因发病机制。
Pediatr Endocrinol Diabetes Metab. 2021;27(1):47-50. doi: 10.5114/pedm.2020.103058.
2
Immunobiology of beta-cell destruction.β细胞破坏的免疫生物学。
Adv Exp Med Biol. 2012;771:194-218. doi: 10.1007/978-1-4614-5441-0_16.
3
In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells.在 1 型糖尿病中,柯萨奇 B4 病毒抗体的亚群可识别自身抗原并诱导胰岛β细胞凋亡。
PLoS One. 2013;8(2):e57729. doi: 10.1371/journal.pone.0057729. Epub 2013 Feb 28.
4
Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.针对 1 型糖尿病的自身免疫及胰岛β细胞功能障碍的个体化细胞治疗选择:现有方案及未来展望。
Adv Exp Med Biol. 2010;654:641-65. doi: 10.1007/978-90-481-3271-3_28.
5
Experiments by nature: lessons on type 1 diabetes.自然实验:1型糖尿病的经验教训
Tissue Antigens. 2014 Jan;83(1):1-9. doi: 10.1111/tan.12280.
6
Molecular mechanisms in autoimmune type 1 diabetes: a critical review.自身免疫性 1 型糖尿病的分子机制:批判性综述。
Clin Rev Allergy Immunol. 2014 Oct;47(2):174-92. doi: 10.1007/s12016-014-8422-2.
7
The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes.胰岛素的阴暗面:1 型糖尿病的主要自身抗原和自我毁灭工具。
Mol Metab. 2021 Oct;52:101288. doi: 10.1016/j.molmet.2021.101288. Epub 2021 Jul 7.
8
Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes.1型糖尿病中胰腺β细胞死亡的介质和机制
Arq Bras Endocrinol Metabol. 2008 Mar;52(2):156-65. doi: 10.1590/s0004-27302008000200003.
9
Histology of Type 1 Diabetes Pancreas.1型糖尿病胰腺的组织学
Methods Mol Biol. 2016;1433:105-17. doi: 10.1007/7651_2015_287.
10
Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.趋化因子在 1 型糖尿病自身免疫破坏中的作用:考虑到最佳治疗方案,为治疗干预提供机会。
Front Endocrinol (Lausanne). 2020 Oct 19;11:591083. doi: 10.3389/fendo.2020.591083. eCollection 2020.

引用本文的文献

1
Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro.人参皂苷Rg1通过AMPK/mTOR途径在体内外改善胰腺损伤。
Diabetes Metab Syndr Obes. 2023 Mar 15;16:779-794. doi: 10.2147/DMSO.S401642. eCollection 2023.
2
Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD mice.细菌样颗粒(BLPs)口服递呈双自体抗原防治 NOD 小鼠自身免疫性糖尿病。
Drug Deliv. 2023 Dec;30(1):2173339. doi: 10.1080/10717544.2023.2173339.
3
Type 2 Diabetes Mellitus, Platelet Activation and Alzheimer's Disease: A Possible Connection.2型糖尿病、血小板活化与阿尔茨海默病:一种可能的联系。
Clin Neuropsychiatry. 2022 Dec;19(6):370-378. doi: 10.36131/cnfioritieditore20220604.
4
Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T Variant for Immunotherapy in Endocrine Autoimmunity.用唾液酸类似物改良脂质体以针对内分泌自身免疫中的 C1858T 变体进行免疫治疗。
Front Immunol. 2022 Mar 9;13:838331. doi: 10.3389/fimmu.2022.838331. eCollection 2022.
5
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice.细菌样颗粒(BLPs)口服递送胰岛淀粉样多肽 2(IA-2ic)的细胞内结构域可预防 NOD 小鼠 1 型糖尿病。
Drug Deliv. 2022 Dec;29(1):925-936. doi: 10.1080/10717544.2022.2053760.

本文引用的文献

1
Analysis of potential hub genes involved in the pathogenesis of Chinese type 1 diabetic patients.中国1型糖尿病患者发病机制中潜在关键基因的分析
Ann Transl Med. 2020 Mar;8(6):295. doi: 10.21037/atm.2020.02.171.
2
Association of Zinc Transporter-8 Autoantibody (ZnT8A) with Type 1 Diabetes Mellitus.锌转运体8自身抗体(ZnT8A)与1型糖尿病的关联
Cureus. 2020 Mar 13;12(3):e7263. doi: 10.7759/cureus.7263.
3
Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.评估肠道微生物群在 1 型糖尿病中的因果作用及其可能的发病机制。
Front Endocrinol (Lausanne). 2020 Mar 24;11:125. doi: 10.3389/fendo.2020.00125. eCollection 2020.
4
Advances in Knowledge of Candidate Genes Acting at the Beta-Cell Level in the Pathogenesis of T1DM.候选基因在 1 型糖尿病发病机制中β细胞水平的作用的研究进展。
Front Endocrinol (Lausanne). 2020 Mar 12;11:119. doi: 10.3389/fendo.2020.00119. eCollection 2020.
5
Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.锌转运体 8 自身抗体与谷氨酸脱羧酶和胰岛细胞抗原 2 自身抗体联合应用,可用于日本 1 型糖尿病的诊断和特征分析。
J Diabetes Investig. 2020 Sep;11(5):1181-1187. doi: 10.1111/jdi.13251. Epub 2020 Apr 22.
6
Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes.1 型和 2 型糖尿病多基因风险评分的系统评价。
Int J Mol Sci. 2020 Mar 2;21(5):1703. doi: 10.3390/ijms21051703.
7
Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development.白细胞介素-6 和白细胞介素-15 作为自身免疫性糖尿病发病风险的可能生物标志物。
Biomed Res Int. 2019 Oct 20;2019:4734063. doi: 10.1155/2019/4734063. eCollection 2019.
8
The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.蛋白质组学在评估 1 型糖尿病中β细胞功能障碍和死亡中的作用。
Expert Rev Proteomics. 2019 Jul;16(7):569-582. doi: 10.1080/14789450.2019.1634548. Epub 2019 Jun 24.
9
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.抗 CD3 抗体,特利珠单抗,用于 1 型糖尿病风险亲属。
N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9.
10
The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes.1 型糖尿病中自身抗原的发现和鉴定的不断发展的领域。
Diabetes. 2019 May;68(5):879-886. doi: 10.2337/dbi18-0066.

β 细胞的自身破坏和 1 型糖尿病极其复杂且仍未知的病因发病机制。

β-cell self-destruction and extremely complicated and still unknown etiopathogenesis of type 1 diabetes.

机构信息

Department of Pharmacology, Medical University of Silesia, Poland.

Inpatient Department of Radiation and Clinical Oncology, Maria Skłodowska-Curie Institute - Oncology Center, Gliwice Branch, Poland.

出版信息

Pediatr Endocrinol Diabetes Metab. 2021;27(1):47-50. doi: 10.5114/pedm.2020.103058.

DOI:10.5114/pedm.2020.103058
PMID:33599437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10227476/
Abstract

Type 1 diabetes is based on apoptosis, which leads to b-cell death. Factors triggering apoptosis processes are very diverse and currently not fully explained. The main role is attributed to genetic and environmental factors. Genetic studies have shown that the inherited propensity for type 1 diabetes is multi-genetic. Environmental factors modify the response to their own antigens, but are probably not necessary to start the autoaggression process. The effect of b-cell destruction is confirmed by the appearance of autoantibodies in the blood. The paper presents a review of the available literature regarding the self-destruction of pancreatic b-cells. The aim of the study was to draw attention to the extremely complicated and still unknown etiopathogenesis of type 1 diabetes by reviewing current literature related to the above topic. The goal is to acquire the knowledge necessary to develop and implement causal treatment for diabetes. At the moment, unfortunately, we do not have safe, innovative therapy methods in the field of diabetes prevention. Intensive research on the etiopathogenesis of type 1 diabetes is an extremely important field of medical research.

摘要

1 型糖尿病是基于细胞凋亡的,这导致了β细胞的死亡。触发细胞凋亡过程的因素非常多样化,目前尚未完全解释清楚。主要作用归因于遗传和环境因素。遗传研究表明,1 型糖尿病的遗传易感性是多基因的。环境因素改变了对自身抗原的反应,但可能不是启动自身免疫攻击过程所必需的。β细胞破坏的作用通过血液中出现自身抗体得到证实。本文综述了关于胰腺β细胞自身破坏的现有文献。本研究的目的是通过回顾与上述主题相关的当前文献,引起人们对 1 型糖尿病极其复杂且仍未知的病因发病机制的关注。目的是获得必要的知识,以便为糖尿病开发和实施因果治疗。不幸的是,目前我们在糖尿病预防领域还没有安全、创新的治疗方法。对 1 型糖尿病病因发病机制的深入研究是医学研究的一个极其重要的领域。